Literature DB >> 2344358

Combined regulation of ornithine and S-adenosylmethionine decarboxylases by spermine and the spermine analogue N1 N12-bis(ethyl)spermine.

C W Porter1, A E Pegg, B Ganis, R Madhabala, R J Bergeron.   

Abstract

In the present study, the spermine (SPM) analogue N1N12-bis(ethyl)spermine (BESPM) is compared with SPM in its ability to regulate ornithine decarboxylase (ODC) and S-adenosyl-L-methionine decarboxylase (AdoMetDC) activities in intact L1210 cells and in the mechanism(s) by which this is accomplished. Unlike the comparable spermidine (SPD) analogue N1N8-bis(ethyl)spermidine, which regulates only ODC, BESPM suppresses both ODC and AdoMetDC activities. With 1 microM-SPM or -BESPM, near-maximal suppression of enzyme activity (i.e. less than 70%) was achieved after 2 h for ODC and 12 h for AdoMetDC. After such treatment, ODC activity fully recovered within 2-4 h, and that of AdoMetDC within 12 h, when cells were reseeded into drug-free media. It was deduced that an intracellular accumulation of BESPM or SPM equivalent to only approximately 200-450 pmol/10(6) cells was sufficient to fully invoke ODC regulatory mechanisms. Decreases in both enzyme activities after BESPM or SPM treatment were closely paralleled by concomitant decreases in the amount of enzyme protein. Since cellular ODC or AdoMetDC mRNA was not similarly decreased by either BESPM or SPM treatment, it was concluded that translational and/or post-translational mechanisms were probably responsible for enzyme regulation. In support of the former of these possibilities, it was demonstrated that both BESPM and SPM preferentially inhibited the translation in vitro of ODC and AdoMetDC relative to albumin in a reticulocyte-lysate system. On the basis of the consistent similarities between BESPM and SPM in all parameters studied, it is concluded that the analogue most likely acts by mechanisms identical with those by which SPM acts in suppressing polyamine biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2344358      PMCID: PMC1131413          DOI: 10.1042/bj2680207

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Comparison of the biological effects of four irreversible inhibitors of ornithine decarboxylase in two murine lymphocytic leukemia cell lines.

Authors:  P J Pera; D L Kramer; J R Sufrin; C W Porter
Journal:  Cancer Res       Date:  1986-03       Impact factor: 12.701

2.  Solid-phase extraction and determination of dansyl derivatives of unconjugated and acetylated polyamines by reversed-phase liquid chromatography: improved separation systems for polyamines in cerebrospinal fluid, urine and tissue.

Authors:  P M Kabra; H K Lee; W P Lubich; L J Marton
Journal:  J Chromatogr       Date:  1986-07-11

3.  Effect of putrescine on the synthesis of S-adenosylmethionine decarboxylase.

Authors:  T Kameji; A E Pegg
Journal:  Biochem J       Date:  1987-04-01       Impact factor: 3.857

4.  Regulation of ornithine decarboxylase activity by spermidine and the spermidine analogue N1N8-bis(ethyl)spermidine.

Authors:  C W Porter; F G Berger; A E Pegg; B Ganis; R J Bergeron
Journal:  Biochem J       Date:  1987-03-01       Impact factor: 3.857

Review 5.  Interference with polyamine biosynthesis and/or function by analogs of polyamines or methionine as a potential anticancer chemotherapeutic strategy.

Authors:  C W Porter; J R Sufrin
Journal:  Anticancer Res       Date:  1986 Jul-Aug       Impact factor: 2.480

6.  Transcriptional activation of mammalian ornithine decarboxylase during stimulated growth.

Authors:  A Katz; C Kahana
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

7.  Inhibition of translation of mRNAs for ornithine decarboxylase and S-adenosylmethionine decarboxylase by polyamines.

Authors:  T Kameji; A E Pegg
Journal:  J Biol Chem       Date:  1987-02-25       Impact factor: 5.157

8.  Polyamine administration reduces ornithine decarboxylase activity without affecting its mRNA content.

Authors:  G J Sertich; A E Pegg
Journal:  Biochem Biophys Res Commun       Date:  1987-03-13       Impact factor: 3.575

9.  Relative abilities of bis(ethyl) derivatives of putrescine, spermidine, and spermine to regulate polyamine biosynthesis and inhibit L1210 leukemia cell growth.

Authors:  C W Porter; J McManis; R A Casero; R J Bergeron
Journal:  Cancer Res       Date:  1987-06-01       Impact factor: 12.701

10.  Biological properties of N4- and N1,N8-spermidine derivatives in cultured L1210 leukemia cells.

Authors:  C W Porter; P F Cavanaugh; N Stolowich; B Ganis; E Kelly; R J Bergeron
Journal:  Cancer Res       Date:  1985-05       Impact factor: 12.701

View more
  12 in total

1.  Design, Synthesis, and Testing of Polyamine Vectored Iron Chelators.

Authors:  Raymond J Bergeron; Shailendra Singh; Neelam Bharti; Yi Jiang
Journal:  Synthesis (Stuttg)       Date:  2010       Impact factor: 3.157

2.  Effects of ethyl and benzyl analogues of spermine on Escherichia coli peptidyltransferase activity, polyamine transport, and cellular growth.

Authors:  P Karahalios; I Amarantos; P Mamos; D Papaioannou; D L Kalpaxis
Journal:  J Bacteriol       Date:  1999-07       Impact factor: 3.490

3.  Phase 1 study of N1-N11-diethylnorspermine (DENSPM) administered TID for 6 days in patients with advanced malignancies.

Authors:  R R Streiff; J F Bender
Journal:  Invest New Drugs       Date:  2001       Impact factor: 3.850

4.  Transgenic mice overexpressing ornithine and S-adenosylmethionine decarboxylases maintain a physiological polyamine homoeostasis in their tissues.

Authors:  R Heljasvaara; I Veress; M Halmekytö; L Alhonen; J Jänne; P Laajala; A Pajunen
Journal:  Biochem J       Date:  1997-04-15       Impact factor: 3.857

5.  Rapid induction of apoptosis by deregulated uptake of polyamine analogues.

Authors:  R H Hu; A E Pegg
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

6.  Regulatory and antiproliferative effects of N-alkylated polyamine analogues in human and hamster pancreatic adenocarcinoma cell lines.

Authors:  B K Chang; R J Bergeron; C W Porter; J R Vinson; Y Liang; P R Libby
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

7.  Phase I trial of the polyamine analog N1,N14-diethylhomospermine (DEHSPM) in patients with advanced solid tumors.

Authors:  George Wilding; David King; Kendra Tutsch; Marcia Pomplun; Chris Feierabend; Dona Alberti; Rhoda Arzoomanian
Journal:  Invest New Drugs       Date:  2004-04       Impact factor: 3.850

Review 8.  Design of polyamine-based therapeutic agents: new targets and new directions.

Authors:  M D Thulani Senanayake; Hemali Amunugama; Tracey D Boncher; Robert A Casero; Patrick M Woster
Journal:  Essays Biochem       Date:  2009-11-04       Impact factor: 8.000

9.  Investigations of the mechanism by which mammalian cell growth is inhibited by N1N12-bis(ethyl)spermine.

Authors:  L Albanese; R J Bergeron; A E Pegg
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

10.  Regulation of S-adenosylmethionine decarboxylase activity by alterations in the intracellular polyamine content.

Authors:  L M Shantz; I Holm; O A Jänne; A E Pegg
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.